NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

But they did not PR that the trial would remain blinded. They PR'd that NWBO would remain blinded. And that would mean they would not know the results until the full analysis is complete. -- exwannabe

Not necessarily. As you already, agree:

"Yes, that trial (AMGEN) continued on blinded after top line data. This would be like NWBO releasing top line PFS data and maintaining the trial blind as they wait on OS." -- exwannabe

You must realize then that NWBO stated this:

"The Company remains blinded to all Trial data, and is only receiving and reporting updates on a blinded basis."

Amgen received and shared data on a blinded basis. Still, they received and shared topline data and maintained the trial blind thereafter.